The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01774058

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Prim PD Dr Afshin Assadian (from the registry)
Registry
  • NCT NCT01774058
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01774058. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2019-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation
Acronym
ILOFLOW
Condition
Diabetes
Condition
Arteriosclerosis
Condition
Peripheral Arterial Occlusive Disease
Condition
Neuropathy
Intervention (Drug)
Ilomedin
Lead sponsor
Prim PD Dr Afshin Assadian (class: other)
Collaborator
Wilhelminenspital Vienna (class: other)

Record details

Record id
cardio:ct-nct01774058
Content hash
20ac119ce22833b8124ec149b1f88b329836ab68022954ca2d58c0073f9f6cc4